This highlighted the importance of some treatment strategies, such as avoiding drugs that overstimulate beta cells and initiating insulin therapy at an appropriate time to preserve endogenous beta cell activity in the progression of type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.